Allon Therapeutics Inc.

Location:

Suite 506, 1168 Hamilton StreetVancouverBritish ColumbiaV6B 2S2Canada View Map

Revenue:

$1.6 Million

Employees:

8

SIC Codes:

2836, 2834

NAICS Codes:

325412, 325414

Phone:

(604) 736-0634

Fax:

(604) 736-1616
More

Description:

Allon Therapeutics Inc. is a clinical-stage biotechnology company focused on bringing to market innovative central nervous system therapies. Allon's lead drug davunetide is proceeding in a pivotal clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA). The trial is fully enrolled and on track to complete the study, analyse the data and release top-line results before the end of 2012. This pivotal trial is based upon statistically significant human efficacy demonstrated in patients with amnestic mild cognitive impairment, cognitive impairment associated with schizophrenia, and in positive biomarker data. The Company is listed on the Toronto Stock Exchange under the trading symbol "NPC".

Read More

Competitors

Recently Updated profiles at this company

Vice President of Business Development

Browse ZoomInfo’s Directories